# Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect)

> **NCT01257828** · PHASE3 · COMPLETED · sponsor: **AOSpine North America Research Network** · enrollment: 270 (actual)

## Conditions studied

- Cervical Spondylotic Myelopathy

## Interventions

- **DRUG:** riluzole
- **DRUG:** Placebo medication

## Key facts

- **NCT ID:** NCT01257828
- **Lead sponsor:** AOSpine North America Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2017-12-15
- **Final completion:** 2018-06-01
- **Target enrollment:** 270 (ACTUAL)
- **Last updated:** 2018-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01257828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01257828, "Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01257828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*